Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Atopic dermatitis increases the risk of some autoimmune diseases.

The document concludes that scalp conditions have various causes and can present in many different ways.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Finger length ratios might predict risk for skin condition in males.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.